公开(公告)号：US20120135413A1

公开(公告)日：2012-05-31

申请号：US13265758

申请日：2010-04-23

申请人： Jason Brown ,  Bas Reichert

发明人： Jason Brown ,  Bas Reichert

IPC分类号： C12Q1/68 ,  B05B1/00

摘要： A composition comprising: a plurality of identical first synthetic nucleotide oligomers; and a plurality of identical second synthetic nucleotide oligomers which are different to the first synthetic nucleotide oligomers, wherein each of the first synthetic nucleotide oligomers comprises a first primer binding sequence of bases, a first identifier sequence of three to seven bases in length, and a second primer binding sequence of bases, the first identifier sequence being disposed between the first and second primer binding sequences, wherein each of the second synthetic nucleotide oligomers comprises a third primer binding sequence of bases, a second identifier sequence of three to seven bases in length, and a fourth primer binding sequence of bases, the second identifier sequence being disposed between the third and fourth primer binding sequences, and wherein the first identifier sequence is different to the second identifier sequence.

摘要翻译： 一种组合物，其包含：多个相同的第一合成核苷酸寡聚体; 和与第一合成核苷酸寡聚体不同的多个相同的第二合成核苷酸寡聚物，其中第一合成核苷酸寡聚体中的每一个包含碱基的第一引物结合序列，长度为三至七个碱基的第一标识符序列，和 第一引物结合序列的碱基，第一标识符序列位于第一和第二引物结合序列之间，其中第二合成核苷酸寡聚体中的每一个包含碱基的第三引物结合序列，长度为三至七个碱基的第二标识符序列 和碱基的第四引物结合序列，第二标识符序列设置在第三和第四引物结合序列之间，并且其中第一标识符序列与第二标识符序列不同。

公开(公告)号：US10472676B2

公开(公告)日：2019-11-12

申请号：US13265758

申请日：2010-04-23

申请人： Jason Brown ,  Bas Reichert

发明人： Jason Brown ,  Bas Reichert

IPC分类号： C12Q1/68 ,  C12Q1/6876 ,  C12Q1/6813

摘要： A composition comprising: a plurality of identical first synthetic nucleotide oligomers; and a plurality of identical second synthetic nucleotide oligomers which are different to the first synthetic nucleotide oligomers, wherein each of the first synthetic nucleotide oligomers comprises a first primer binding sequence of bases, a first identifier sequence of three to seven bases in length, and a second primer binding sequence of bases, the first identifier sequence being disposed between the first and second primer binding sequences, wherein each of the second synthetic nucleotide oligomers comprises a third primer binding sequence of bases, a second identifier sequence of three to seven bases in length, and a fourth primer binding sequence of bases, the second identifier sequence being disposed between the third and fourth primer binding sequences, and wherein the first identifier sequence is different to the second identifier sequence.